{"id":369493,"date":"2025-09-01T19:49:26","date_gmt":"2025-09-01T19:49:26","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-abbott-laboratories\/"},"modified":"2025-09-01T19:49:26","modified_gmt":"2025-09-01T19:49:26","slug":"how-to-buy-abbott-laboratories","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/","title":{"rendered":"How to buy Abbott Laboratories (0Q15) shares &#8211; Investment in Abbott Laboratories (0Q15) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-369493","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Abbott Laboratories (0Q15) Shares - Investment in Abbott Laboratories (0Q15) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Abbott Laboratories (0Q15) Shares - Investment in Abbott Laboratories (0Q15) Stock"},"description":"Learn how to buy Abbott Laboratories (0Q15) shares and make smart investment decisions. Discover current stock performance, growth potential, and step-by-step purchasing process.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Abbott Laboratories (0Q15) shares and make smart investment decisions. Discover current stock performance, growth potential, and step-by-step purchasing process."},"intro":"Thinking about investing in healthcare innovation? Abbott Laboratories represents one of the most stable yet dynamic opportunities in the medical sector. With over 135 years of experience and a diversified portfolio spanning diagnostics, medical devices, nutrition, and pharmaceuticals, this company touches millions of lives daily. Whether you're building long-term wealth or seeking exposure to healthcare growth, understanding how to buy Abbott Laboratories (0Q15) shares could be your gateway to smart investing.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in healthcare innovation? Abbott Laboratories represents one of the most stable yet dynamic opportunities in the medical sector. With over 135 years of experience and a diversified portfolio spanning diagnostics, medical devices, nutrition, and pharmaceuticals, this company touches millions of lives daily. Whether you're building long-term wealth or seeking exposure to healthcare growth, understanding how to buy Abbott Laboratories (0Q15) shares could be your gateway to smart investing."},"body_html":"<h2>\ud83d\udcc8 Current Market Position and Entry Timing<\/h2> <p>As of September 1, 2025, Abbott Laboratories (ABT) trades at <strong>$132.66<\/strong> on the NYSE. The stock has demonstrated remarkable resilience, currently sitting just 6.5% below its 52-week high of $141.23 while maintaining a comfortable 16.4% cushion above its 52-week low.<\/p> <p><strong>Critical Date Alert<\/strong>: Mark <strong>October 15, 2025<\/strong> on your calendar! This is when Abbott releases its Q3 earnings report. Historical data shows these announcements typically create significant price movements.<\/p> <h3>Earnings Impact Analysis: Learning from History<\/h3> <p>Looking at recent quarterly reports reveals fascinating patterns:<\/p> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Pre-News Price<\/th><th>Post-News Change<\/th><th>Key Insight<\/th><\/tr> <\/thead> <tbody> <tr><td>July 17, 2025<\/td><td>Q2 Earnings<\/td><td>$137.41<\/td><td>-5% pre-market<\/td><td>Beat estimates but conservative guidance spooked investors<\/td><\/tr> <tr><td>April 2025<\/td><td>Q1 Earnings<\/td><td>$128.50<\/td><td>+3.2% weekly<\/td><td>Strong device sales drove optimism<\/td><\/tr> <tr><td>January 2025<\/td><td>Annual Guidance<\/td><td>$125.80<\/td><td>+4.5% monthly<\/td><td>Upbeat outlook for medical devices<\/td><\/tr> <tr><td>October 2024<\/td><td>Q3 2024<\/td><td>$121.30<\/td><td>+2.8% weekly<\/td><td>Diabetes care growth impressed markets<\/td><\/tr> <tr><td>July 2024<\/td><td>Q2 2024<\/td><td>$118.90<\/td><td>+1.9%<\/td><td>Steady performance across segments<\/td><\/tr> <tr><td>April 2024<\/td><td>Q1 2024<\/td><td>$115.20<\/td><td>+3.1%<\/td><td>Emerging markets strength highlighted<\/td><\/tr> <\/tbody> <\/table> <p><strong>Pattern Insight<\/strong>: Positive earnings surprises typically boost prices by 3-6% within days, while conservative guidance (even with good results) can cause short-term dips of 4-7%. The July 2025 drop despite beating estimates shows how forward-looking statements matter more than historical performance.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udcca Six-Month Performance Journey (March-September 2025)<\/h2> <p>Abbott's stock has delivered an impressive <strong>18% year-to-date return<\/strong>, significantly outperforming the S&P 500's 6% growth. Here's how the journey unfolded:<\/p> <table> <thead> <tr><th>Period<\/th><th>Price Level<\/th><th>Key Driver<\/th><\/tr> <\/thead> <tbody> <tr><td>March 2025<\/td><td>$138.95 (ATH)<\/td><td>Medical device sales surge +14.8%<\/td><\/tr> <tr><td>April 2025<\/td><td>$134.20<\/td><td>Market consolidation after peak<\/td><\/tr> <tr><td>May 2025<\/td><td>$130.50<\/td><td>Broader healthcare sector adjustment<\/td><\/tr> <tr><td>June 2025<\/td><td>$128.80<\/td><td>Summer volatility period<\/td><\/tr> <tr><td>July 2025<\/td><td>$132.10<\/td><td>Q2 earnings anticipation<\/td><\/tr> <tr><td>August 2025<\/td><td>$131.37<\/td><td>Post-earnings digestion<\/td><\/tr> <tr><td>September 1, 2025<\/td><td>$132.66<\/td><td>Recovery momentum building<\/td><\/tr> <\/tbody> <\/table> <p>The stock's resilience stems from Abbott's diversified business model: when diagnostics faced headwinds from reduced COVID testing, medical devices picked up the slack with 13.4% growth. This balanced approach makes ABT less vulnerable to sector-specific challenges.<\/p> <h2>\ud83d\udd2e Price Forecast: Strategic Outlook 2025-2030<\/h2> <p>Based on comprehensive analyst consensus and current fundamentals, here's what to expect:<\/p> <ul> <li><strong>2025 Year-End<\/strong>: $142-145 range (+7-9% from current) \u2192 <strong>STRONG BUY<\/strong><br> Rationale: Q4 typically strongest for medical devices, holiday season boosts nutritional sales<\/li> <li><strong>2026 Projection<\/strong>: $190-195 range (+43-47% from current)<br> Catalysts: New product launches in diabetes care, emerging market expansion<\/li> <li><strong>2028 Outlook<\/strong>: $220-225 range (+66-70% from current)<br> Growth Drivers: Aging population demand, technological innovations in cardiac care<\/li> <li><strong>2030 Vision<\/strong>: $140-145 range (conservative) to $155-160 (optimistic)<br> Considerations: Market saturation potential vs. innovation breakthroughs<\/li> <\/ul> <p><strong>Verdict<\/strong>: Current levels offer excellent entry point for long-term investors. The 2026-2028 period appears particularly promising given demographic trends and product pipeline.<\/p> <h2>\u26a0\ufe0f Risk Assessment: Navigating Potential Challenges<\/h2> <h3>Major Risk Factors<\/h3> <ol> <li><strong>Regulatory Changes<\/strong>: Healthcare policy shifts could impact pricing and reimbursement<\/li> <li><strong>Currency Exposure<\/strong>: 70% international revenue creates forex volatility risk<\/li> <li><strong>Competition Intensification<\/strong>: New entrants in diabetes monitoring and cardiac devices<\/li> <li><strong>Supply Chain Disruptions<\/strong>: Global operations vulnerable to geopolitical tensions<\/li> <li><strong>Product Liability<\/strong>: Medical device recalls can significantly impact reputation and costs<\/li> <\/ol> <h3>Positive Signals for 2025<\/h3> <ol> <li><strong>Medical Device Momentum<\/strong>: 14.8% US growth indicates strong demand<\/li> <li><strong>Emerging Market Strength<\/strong>: 8.7% organic growth in key developing regions<\/li> <li><strong>Innovation Pipeline<\/strong>: New product approvals throughout 2025<\/li> <li><strong>Margin Expansion<\/strong>: 100 basis point improvement in operating margins<\/li> <li><strong>Dividend Consistency<\/strong>: 405th consecutive quarterly dividend declaration<\/li> <\/ol> <h2>\ud83d\udcf0 Significant News Analysis: Last Six Months<\/h2> <h3>Q2 2025 Earnings Deep Dive (July 17, 2025)<\/h3> <p>Abbott delivered a classic \"beat and lower\" scenario: exceeding Q2 estimates but providing cautious forward guidance. Revenue of $11.14 billion beat expectations by 0.6%, while adjusted EPS of $1.26 surpassed estimates by 0.8%. However, the stock dropped 5% pre-market due to reserved Q3 outlook.<\/p> <p><strong>Trader Takeaway<\/strong>: This creates a potential buying opportunity. When solid companies experience short-term dips due to guidance concerns rather than fundamental problems, it often presents excellent entry points.<\/p> <h3>Operational Highlights<\/h3> <ul> <li><strong>Medical Devices<\/strong>: +13.4% growth, driven by diabetes care (+21.4%)<\/li> <li><strong>Emerging Markets<\/strong>: +8.7% organic growth across Asia and Latin America<\/li> <li><strong>Margin Improvement<\/strong>: Both gross and operating margins expanded by 100 basis points<\/li> <\/ul> <h3>Insider Activity Context<\/h3> <p>The August 8, 2025 Form 144 filing for 5,550 shares ($746,758 value) represents routine vested stock sales rather than concerning insider behavior. Such small transactions by executives typically don't signal fundamental issues.<\/p> <h2>\ud83c\udfaf Beginner Trader Action Plan Today<\/h2> <h3>Serious Recommendations:<\/h3> <ol> <li><strong>Dollar-Cost Average<\/strong>: Start with small regular purchases rather than timing a single entry<\/li> <li><strong>Earnings Strategy<\/strong>: Consider buying any post-earnings dip around October 15th<\/li> <li><strong>Sector Diversification<\/strong>: Keep healthcare exposure below 20% of total portfolio<\/li> <\/ol> <h3>Humorous Veteran Insight:<\/h3> <p>\"Trading ABT is like dating a reliable partner - they might not create dramatic fireworks every day, but they'll be there when you really need them during market turbulence. Just don't expect them to suddenly become a rockstar overnight!\"<\/p> <h2>\u2705 How to Buy Abbott Laboratories (0Q15) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a Trading Platform<\/td><td>Ensure it offers NYSE-listed stocks and fractional shares<\/td><\/tr> <tr><td>2<\/td><td>Complete Account Verification<\/td><td>Typically requires ID and proof of address documents<\/td><\/tr> <tr><td>3<\/td><td>Deposit Funds<\/td><td>Start with an amount you're comfortable risking initially<\/td><\/tr> <tr><td>4<\/td><td>Search for \"ABT\"<\/td><td>Use the ticker symbol for accurate identification<\/td><\/tr> <tr><td>5<\/td><td>Select Order Type<\/td><td>Use limit orders to control entry price rather than market orders<\/td><\/tr> <tr><td>6<\/td><td>Review Order Details<\/td><td>Check commission fees and settlement timeframe<\/td><\/tr> <tr><td>7<\/td><td>Execute Purchase<\/td><td>Confirm order and wait for execution confirmation<\/td><\/tr> <tr><td>8<\/td><td>Set Price Alerts<\/td><td>Monitor key levels like $140 resistance and $125 support<\/td><\/tr> <tr><td>9<\/td><td>Document Transaction<\/td><td>Keep records for tax purposes and performance tracking<\/td><\/tr> <tr><td>10<\/td><td>Plan Exit Strategy<\/td><td>Determine profit-taking and stop-loss levels in advance<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Complements Long-Term Investing<\/h2> <p>While Abbott Laboratories represents an excellent long-term investment, platforms like Pocket Option offer unique advantages for newer investors:<\/p> <ul> <li><strong>Minimum Deposit Flexibility<\/strong>: With just $5, you can begin your investment journey without significant capital commitment<\/li> <li><strong>Rapid Verification<\/strong>: The 1-minute KYC process using any single document means you can start trading almost immediately<\/li> <li><strong>Diverse Withdrawal Options<\/strong>: Over 100 withdrawal methods provide flexibility in accessing your profits<\/li> <li><strong>Educational Resources<\/strong>: The <a href=\"\/blog\">Pocket Option blog<\/a> offers continuous learning opportunities to enhance your investment knowledge<\/li> <\/ul> <p>This combination of long-term stock ownership through traditional brokers and quick trading opportunities through platforms like Pocket Option creates a balanced approach to wealth building.<\/p> <h2>\ud83c\udf0d Abbott Laboratories: Healthcare Innovation Leader<\/h2> <p>Abbott stands as one of the world's most diversified healthcare companies, operating four roughly equal-sized business segments across 160+ countries. The company's strategic balance across medical devices, diagnostics, nutrition, and pharmaceuticals provides remarkable stability while offering growth exposure to global healthcare trends.<\/p> <p><strong>Current Market Position<\/strong>: <\/p> <ul> <li>18% market share in US cardiovascular devices<\/li> <li>Tests approximately half the world's blood supply<\/li> <li>70% of revenue from international markets<\/li> <li>114,000 employees worldwide<\/li> <\/ul> <p><strong>2025 Interesting Fact<\/strong>: Abbott made medical history by performing the first-in-world leadless pacing procedures in the left bundle branch area of the heart - a breakthrough that could revolutionize cardiac rhythm management for millions of patients worldwide.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Current Market Position and Entry Timing<\/h2>\n<p>As of September 1, 2025, Abbott Laboratories (ABT) trades at <strong>$132.66<\/strong> on the NYSE. The stock has demonstrated remarkable resilience, currently sitting just 6.5% below its 52-week high of $141.23 while maintaining a comfortable 16.4% cushion above its 52-week low.<\/p>\n<p><strong>Critical Date Alert<\/strong>: Mark <strong>October 15, 2025<\/strong> on your calendar! This is when Abbott releases its Q3 earnings report. Historical data shows these announcements typically create significant price movements.<\/p>\n<h3>Earnings Impact Analysis: Learning from History<\/h3>\n<p>Looking at recent quarterly reports reveals fascinating patterns:<\/p>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Pre-News Price<\/th>\n<th>Post-News Change<\/th>\n<th>Key Insight<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>July 17, 2025<\/td>\n<td>Q2 Earnings<\/td>\n<td>$137.41<\/td>\n<td>-5% pre-market<\/td>\n<td>Beat estimates but conservative guidance spooked investors<\/td>\n<\/tr>\n<tr>\n<td>April 2025<\/td>\n<td>Q1 Earnings<\/td>\n<td>$128.50<\/td>\n<td>+3.2% weekly<\/td>\n<td>Strong device sales drove optimism<\/td>\n<\/tr>\n<tr>\n<td>January 2025<\/td>\n<td>Annual Guidance<\/td>\n<td>$125.80<\/td>\n<td>+4.5% monthly<\/td>\n<td>Upbeat outlook for medical devices<\/td>\n<\/tr>\n<tr>\n<td>October 2024<\/td>\n<td>Q3 2024<\/td>\n<td>$121.30<\/td>\n<td>+2.8% weekly<\/td>\n<td>Diabetes care growth impressed markets<\/td>\n<\/tr>\n<tr>\n<td>July 2024<\/td>\n<td>Q2 2024<\/td>\n<td>$118.90<\/td>\n<td>+1.9%<\/td>\n<td>Steady performance across segments<\/td>\n<\/tr>\n<tr>\n<td>April 2024<\/td>\n<td>Q1 2024<\/td>\n<td>$115.20<\/td>\n<td>+3.1%<\/td>\n<td>Emerging markets strength highlighted<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Pattern Insight<\/strong>: Positive earnings surprises typically boost prices by 3-6% within days, while conservative guidance (even with good results) can cause short-term dips of 4-7%. The July 2025 drop despite beating estimates shows how forward-looking statements matter more than historical performance.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca Six-Month Performance Journey (March-September 2025)<\/h2>\n<p>Abbott&#8217;s stock has delivered an impressive <strong>18% year-to-date return<\/strong>, significantly outperforming the S&#038;P 500&#8217;s 6% growth. Here&#8217;s how the journey unfolded:<\/p>\n<table>\n<thead>\n<tr>\n<th>Period<\/th>\n<th>Price Level<\/th>\n<th>Key Driver<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>March 2025<\/td>\n<td>$138.95 (ATH)<\/td>\n<td>Medical device sales surge +14.8%<\/td>\n<\/tr>\n<tr>\n<td>April 2025<\/td>\n<td>$134.20<\/td>\n<td>Market consolidation after peak<\/td>\n<\/tr>\n<tr>\n<td>May 2025<\/td>\n<td>$130.50<\/td>\n<td>Broader healthcare sector adjustment<\/td>\n<\/tr>\n<tr>\n<td>June 2025<\/td>\n<td>$128.80<\/td>\n<td>Summer volatility period<\/td>\n<\/tr>\n<tr>\n<td>July 2025<\/td>\n<td>$132.10<\/td>\n<td>Q2 earnings anticipation<\/td>\n<\/tr>\n<tr>\n<td>August 2025<\/td>\n<td>$131.37<\/td>\n<td>Post-earnings digestion<\/td>\n<\/tr>\n<tr>\n<td>September 1, 2025<\/td>\n<td>$132.66<\/td>\n<td>Recovery momentum building<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The stock&#8217;s resilience stems from Abbott&#8217;s diversified business model: when diagnostics faced headwinds from reduced COVID testing, medical devices picked up the slack with 13.4% growth. This balanced approach makes ABT less vulnerable to sector-specific challenges.<\/p>\n<h2>\ud83d\udd2e Price Forecast: Strategic Outlook 2025-2030<\/h2>\n<p>Based on comprehensive analyst consensus and current fundamentals, here&#8217;s what to expect:<\/p>\n<ul>\n<li><strong>2025 Year-End<\/strong>: $142-145 range (+7-9% from current) \u2192 <strong>STRONG BUY<\/strong><br \/> Rationale: Q4 typically strongest for medical devices, holiday season boosts nutritional sales<\/li>\n<li><strong>2026 Projection<\/strong>: $190-195 range (+43-47% from current)<br \/> Catalysts: New product launches in diabetes care, emerging market expansion<\/li>\n<li><strong>2028 Outlook<\/strong>: $220-225 range (+66-70% from current)<br \/> Growth Drivers: Aging population demand, technological innovations in cardiac care<\/li>\n<li><strong>2030 Vision<\/strong>: $140-145 range (conservative) to $155-160 (optimistic)<br \/> Considerations: Market saturation potential vs. innovation breakthroughs<\/li>\n<\/ul>\n<p><strong>Verdict<\/strong>: Current levels offer excellent entry point for long-term investors. The 2026-2028 period appears particularly promising given demographic trends and product pipeline.<\/p>\n<h2>\u26a0\ufe0f Risk Assessment: Navigating Potential Challenges<\/h2>\n<h3>Major Risk Factors<\/h3>\n<ol>\n<li><strong>Regulatory Changes<\/strong>: Healthcare policy shifts could impact pricing and reimbursement<\/li>\n<li><strong>Currency Exposure<\/strong>: 70% international revenue creates forex volatility risk<\/li>\n<li><strong>Competition Intensification<\/strong>: New entrants in diabetes monitoring and cardiac devices<\/li>\n<li><strong>Supply Chain Disruptions<\/strong>: Global operations vulnerable to geopolitical tensions<\/li>\n<li><strong>Product Liability<\/strong>: Medical device recalls can significantly impact reputation and costs<\/li>\n<\/ol>\n<h3>Positive Signals for 2025<\/h3>\n<ol>\n<li><strong>Medical Device Momentum<\/strong>: 14.8% US growth indicates strong demand<\/li>\n<li><strong>Emerging Market Strength<\/strong>: 8.7% organic growth in key developing regions<\/li>\n<li><strong>Innovation Pipeline<\/strong>: New product approvals throughout 2025<\/li>\n<li><strong>Margin Expansion<\/strong>: 100 basis point improvement in operating margins<\/li>\n<li><strong>Dividend Consistency<\/strong>: 405th consecutive quarterly dividend declaration<\/li>\n<\/ol>\n<h2>\ud83d\udcf0 Significant News Analysis: Last Six Months<\/h2>\n<h3>Q2 2025 Earnings Deep Dive (July 17, 2025)<\/h3>\n<p>Abbott delivered a classic &#8220;beat and lower&#8221; scenario: exceeding Q2 estimates but providing cautious forward guidance. Revenue of $11.14 billion beat expectations by 0.6%, while adjusted EPS of $1.26 surpassed estimates by 0.8%. However, the stock dropped 5% pre-market due to reserved Q3 outlook.<\/p>\n<p><strong>Trader Takeaway<\/strong>: This creates a potential buying opportunity. When solid companies experience short-term dips due to guidance concerns rather than fundamental problems, it often presents excellent entry points.<\/p>\n<h3>Operational Highlights<\/h3>\n<ul>\n<li><strong>Medical Devices<\/strong>: +13.4% growth, driven by diabetes care (+21.4%)<\/li>\n<li><strong>Emerging Markets<\/strong>: +8.7% organic growth across Asia and Latin America<\/li>\n<li><strong>Margin Improvement<\/strong>: Both gross and operating margins expanded by 100 basis points<\/li>\n<\/ul>\n<h3>Insider Activity Context<\/h3>\n<p>The August 8, 2025 Form 144 filing for 5,550 shares ($746,758 value) represents routine vested stock sales rather than concerning insider behavior. Such small transactions by executives typically don&#8217;t signal fundamental issues.<\/p>\n<h2>\ud83c\udfaf Beginner Trader Action Plan Today<\/h2>\n<h3>Serious Recommendations:<\/h3>\n<ol>\n<li><strong>Dollar-Cost Average<\/strong>: Start with small regular purchases rather than timing a single entry<\/li>\n<li><strong>Earnings Strategy<\/strong>: Consider buying any post-earnings dip around October 15th<\/li>\n<li><strong>Sector Diversification<\/strong>: Keep healthcare exposure below 20% of total portfolio<\/li>\n<\/ol>\n<h3>Humorous Veteran Insight:<\/h3>\n<p>&#8220;Trading ABT is like dating a reliable partner &#8211; they might not create dramatic fireworks every day, but they&#8217;ll be there when you really need them during market turbulence. Just don&#8217;t expect them to suddenly become a rockstar overnight!&#8221;<\/p>\n<h2>\u2705 How to Buy Abbott Laboratories (0Q15) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a Trading Platform<\/td>\n<td>Ensure it offers NYSE-listed stocks and fractional shares<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete Account Verification<\/td>\n<td>Typically requires ID and proof of address documents<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Deposit Funds<\/td>\n<td>Start with an amount you&#8217;re comfortable risking initially<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Search for &#8220;ABT&#8221;<\/td>\n<td>Use the ticker symbol for accurate identification<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Select Order Type<\/td>\n<td>Use limit orders to control entry price rather than market orders<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Review Order Details<\/td>\n<td>Check commission fees and settlement timeframe<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Execute Purchase<\/td>\n<td>Confirm order and wait for execution confirmation<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Set Price Alerts<\/td>\n<td>Monitor key levels like $140 resistance and $125 support<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Document Transaction<\/td>\n<td>Keep records for tax purposes and performance tracking<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Plan Exit Strategy<\/td>\n<td>Determine profit-taking and stop-loss levels in advance<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Complements Long-Term Investing<\/h2>\n<p>While Abbott Laboratories represents an excellent long-term investment, platforms like Pocket Option offer unique advantages for newer investors:<\/p>\n<ul>\n<li><strong>Minimum Deposit Flexibility<\/strong>: With just $5, you can begin your investment journey without significant capital commitment<\/li>\n<li><strong>Rapid Verification<\/strong>: The 1-minute KYC process using any single document means you can start trading almost immediately<\/li>\n<li><strong>Diverse Withdrawal Options<\/strong>: Over 100 withdrawal methods provide flexibility in accessing your profits<\/li>\n<li><strong>Educational Resources<\/strong>: The <a href=\"\/blog\">Pocket Option blog<\/a> offers continuous learning opportunities to enhance your investment knowledge<\/li>\n<\/ul>\n<p>This combination of long-term stock ownership through traditional brokers and quick trading opportunities through platforms like Pocket Option creates a balanced approach to wealth building.<\/p>\n<h2>\ud83c\udf0d Abbott Laboratories: Healthcare Innovation Leader<\/h2>\n<p>Abbott stands as one of the world&#8217;s most diversified healthcare companies, operating four roughly equal-sized business segments across 160+ countries. The company&#8217;s strategic balance across medical devices, diagnostics, nutrition, and pharmaceuticals provides remarkable stability while offering growth exposure to global healthcare trends.<\/p>\n<p><strong>Current Market Position<\/strong>: <\/p>\n<ul>\n<li>18% market share in US cardiovascular devices<\/li>\n<li>Tests approximately half the world&#8217;s blood supply<\/li>\n<li>70% of revenue from international markets<\/li>\n<li>114,000 employees worldwide<\/li>\n<\/ul>\n<p><strong>2025 Interesting Fact<\/strong>: Abbott made medical history by performing the first-in-world leadless pacing procedures in the left bundle branch area of the heart &#8211; a breakthrough that could revolutionize cardiac rhythm management for millions of patients worldwide.<\/p>\n"},"faq":[{"question":"What is the difference between ABT and 0Q15 tickers?","answer":"ABT is the primary ticker on the NYSE, while 0Q15 is the ticker symbol used on some European exchanges and trading platforms for the same Abbott Laboratories stock."},{"question":"How often does Abbott pay dividends?","answer":"Abbott has an exceptional track record of paying dividends for 405 consecutive quarters, typically distributing payments quarterly to shareholders."},{"question":"What is Abbott's biggest growth driver currently?","answer":"Medical devices, particularly diabetes care products like FreeStyle Libre, are driving strongest growth with 21.4% sales increase in Q2 2025."},{"question":"Is Abbott affected by COVID-19 testing demand changes?","answer":"Yes, but diversely. While COVID testing revenue declined from $102M to $55M year-over-year, other segments like medical devices grew significantly to offset this impact."},{"question":"What makes Abbott a good long-term investment?","answer":"Demographic trends (aging population), global middle-class expansion, continuous innovation pipeline, and diversified business model create strong long-term growth fundamentals."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What is the difference between ABT and 0Q15 tickers?","answer":"ABT is the primary ticker on the NYSE, while 0Q15 is the ticker symbol used on some European exchanges and trading platforms for the same Abbott Laboratories stock."},{"question":"How often does Abbott pay dividends?","answer":"Abbott has an exceptional track record of paying dividends for 405 consecutive quarters, typically distributing payments quarterly to shareholders."},{"question":"What is Abbott's biggest growth driver currently?","answer":"Medical devices, particularly diabetes care products like FreeStyle Libre, are driving strongest growth with 21.4% sales increase in Q2 2025."},{"question":"Is Abbott affected by COVID-19 testing demand changes?","answer":"Yes, but diversely. While COVID testing revenue declined from $102M to $55M year-over-year, other segments like medical devices grew significantly to offset this impact."},{"question":"What makes Abbott a good long-term investment?","answer":"Demographic trends (aging population), global middle-class expansion, continuous innovation pipeline, and diversified business model create strong long-term growth fundamentals."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Abbott Laboratories (0Q15) shares - Investment in Abbott Laboratories (0Q15) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Abbott Laboratories (0Q15) shares - Investment in Abbott Laboratories (0Q15) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-01T19:49:26+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Abbott Laboratories (0Q15) shares &#8211; Investment in Abbott Laboratories (0Q15) stock\",\"datePublished\":\"2025-09-01T19:49:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/\",\"name\":\"How to buy Abbott Laboratories (0Q15) shares - Investment in Abbott Laboratories (0Q15) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-09-01T19:49:26+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Abbott Laboratories (0Q15) shares &#8211; Investment in Abbott Laboratories (0Q15) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Abbott Laboratories (0Q15) shares - Investment in Abbott Laboratories (0Q15) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Abbott Laboratories (0Q15) shares - Investment in Abbott Laboratories (0Q15) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/","og_site_name":"Pocket Option blog","article_published_time":"2025-09-01T19:49:26+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Abbott Laboratories (0Q15) shares &#8211; Investment in Abbott Laboratories (0Q15) stock","datePublished":"2025-09-01T19:49:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/","name":"How to buy Abbott Laboratories (0Q15) shares - Investment in Abbott Laboratories (0Q15) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-09-01T19:49:26+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-abbott-laboratories\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Abbott Laboratories (0Q15) shares &#8211; Investment in Abbott Laboratories (0Q15) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":369614,"slug":"how-to-buy-abbott-laboratories-2","post_title":"Comment acheter des actions Abbott Laboratories (0Q15) - Investissement dans les actions Abbott Laboratories (0Q15)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/"},"it_IT":{"locale":"it_IT","id":369607,"slug":"how-to-buy-abbott-laboratories-2","post_title":"Come acquistare azioni Abbott Laboratories (0Q15) - Investire in azioni Abbott Laboratories (0Q15)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/"},"pl_PL":{"locale":"pl_PL","id":369609,"slug":"how-to-buy-abbott-laboratories-2","post_title":"Jak kupi\u0107 akcje Abbott Laboratories (0Q15) - Inwestycja w akcje Abbott Laboratories (0Q15)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/"},"es_ES":{"locale":"es_ES","id":369608,"slug":"how-to-buy-abbott-laboratories-2","post_title":"C\u00f3mo comprar acciones de Abbott Laboratories (0Q15) - Inversi\u00f3n en acciones de Abbott Laboratories (0Q15)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/"},"th_TH":{"locale":"th_TH","id":369611,"slug":"how-to-buy-abbott-laboratories-2","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Abbott Laboratories (0Q15) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Abbott Laboratories (0Q15)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/"},"tr_TR":{"locale":"tr_TR","id":369612,"slug":"how-to-buy-abbott-laboratories-2","post_title":"Abbott Laboratories (0Q15) Hisseleri Nas\u0131l Al\u0131n\u0131r - Abbott Laboratories (0Q15) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/"},"vt_VT":{"locale":"vt_VT","id":369613,"slug":"how-to-buy-abbott-laboratories-2","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Abbott Laboratories (0Q15) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Abbott Laboratories (0Q15)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/"},"pt_AA":{"locale":"pt_AA","id":369610,"slug":"how-to-buy-abbott-laboratories-2","post_title":"Como comprar a\u00e7\u00f5es da Abbott Laboratories (0Q15) - Investimento em a\u00e7\u00f5es da Abbott Laboratories (0Q15)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-abbott-laboratories-2\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/369493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=369493"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/369493\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=369493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=369493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=369493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}